BOSTON UNIVERSITY NAMES FIRST INNOVATOR-OF-THE-YEAR
Contact: Adriane Dean, 617-358-0234 | firstname.lastname@example.org
(Boston) – Boston University Professor Mark W. Grinstaff has won the inaugural Innovator-of-the-Year Award from BU’s Office of Technology Development, recognizing a faculty member who translates research into innovations that benefit humankind. It was awarded at OTD’s first annual networking event, Tech, Drugs, & Rock ‘n Roll, the unofficial kickoff of a university-wide commitment to establish Boston University as the new hub of entrepreneurship in Boston.
A professor of biomedical engineering in the College of Engineering and of chemistry in the College of Arts and Sciences, Grinstaff co-founded three companies now commercializing his research ideas: Hyperbranch Medical Technology (http://www.hyperbranch.com/), Flex Biomedical (http://www.flexbio.com/), and recent start-up Acuity Bio that is commercializing a new drug delivery device for the prevention of tumor recurrence after surgical resection – a significant unmet clinical need. His current work includes research into new macromolecule and amphiphile syntheses, self-assembly chemistry, tissue engineering, and drug delivery.
“Professor Grinstaff is an entrepreneurial scientist, whose practical approach to science has led to the formation of three companies producing beneficial products,” said BU President Robert Brown, who presented the award. “His accomplishments in the past year include 15 peer-reviewed papers published, two invention disclosures, a patent filing, and more than $1 million invested in Flex Biomedical.”
Grinstaff received a Ph.D. from the University of Illinois and was an NIH postdoctoral fellow at the California Institute of Technology. His honors include the ACS Nobel Laureate Signature Award, NSF Career Award, Alfred P. Sloan Research Fellowship, Pew Scholar in the Biomedical Sciences, Camille Dreyfus Teacher-Scholar, and Edward M. Kennedy Award for Health Care Innovation.
The BU Innovator-of-the-Year Award seeks to highlight translational research at BU by recognizing an entrepreneurial faculty member and the potential for commercialization and/or wider adoption of their inventions. It also encourages faculty to become entrepreneurial while promoting role models who can inspire graduate students to pursue entrepreneurial careers.
Founded in 1839, Boston University is an internationally recognized private research university with more than 30,000 students participating in undergraduate, graduate, and professional programs. As Boston University’s largest academic division, the College and Graduate School of Arts & Sciences is the heart of the BU experience with a global reach that enhances the University’s reputation for teaching and research.